Open Veils · Answer
RCCX Theroy how has this progressed since first released
Dr. Sharon Meglathery's RCCX Theory has moved from a fringe integrative hypothesis to a framework increasingly corroborated by genomic sequencing research. The theory posits that copy number variations within the RCCX module create a common genetic foundation linking CAH, Ehlers-Danlos Syndrome, MCAS, POTS, autism, anxiety, and other chronic illness clusters. Long-read Oxford Nanopore sequencing studies published through 2024 are now resolving the fine-structure rearrangements within RCCX at a resolution previously impossible, lending structural credibility to Meglathery's core claims.
Evidence
- Meglathery argued that partial 21-hydroxylase deficiency, too subtle to trigger classic CAH diagnosis, produces chronic cortisol insufficiency and aldosterone dysregulation that sensitizes the entire neuroimmune axis.
- The key mechanism she identified centers on the RCCX module on chromosome 6p21.3 — specifically how tandem duplications and deletions alter dosage of CYP21A2 (21-hydroxylase), TNXB (tenascin-X), and C4A/C4B complement proteins simultaneously, producing what she termed the 'stress-activated phenotype.'
- This sensitized state, she proposed, creates the hypermobile connective tissue, mast cell hyperreactivity, and autonomic instability seen clinically as the EDS-MCAS-POTS triad.
- The psychiatric overlay — including dissociation, sensory processing differences, and PTSD susceptibility — she linked to CRH/cortisol feedback loop dysregulation arising from the same partial enzymatic deficit.
- This kind of high-resolution structural data was unavailable when Meglathery first proposed the theory and now validates the complexity of RCCX rearrangements she was describing clinically.